Kartesada

Pregabalin, the active ingredient in Kartesada, is a gabapentinoid presented as an oral tablet for oral use. It is employed to manage neuropathic pain conditions and as adjunctive therapy for partial seizures in adults. The medication works by modulating calcium channel activity, which helps reduce abnormal neuronal firing associated with pain and seizure activity.

GNH USA supplies Kartesada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Pregabalin is indicated for several neurological and pain‑related conditions where modulation of calcium channels provides therapeutic benefit.

- Diabetic peripheral neuropathy: reduces pain intensity and improves sensory function. - Postherpetic neuralgia: alleviates chronic burning pain after shingles. - Fibromyalgia: lessens widespread musculoskeletal pain and improves functional capacity. - Partial onset seizures: provides adjunctive seizure control in adults.

Pregabalin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Weight gain - Blurred vision - Dry mouth

Serious or Rare Side Effects: - Angioedema or severe allergic reactions - Suicidal thoughts or behavior - Respiratory depression, especially with CNS depressants - Severe skin reactions such as Stevens‑Johnson syndrome - Blood dyscrasias (e.g., agranulocytosis) - Hepatic dysfunction

When prescribing Pregabalin, clinicians should consider several safety factors.

- Renal impairment: dose adjustment may be required due to renal excretion. - Pregnancy: Category C; weigh potential benefits against risks. - Elderly patients: increased sensitivity to CNS effects; start low and titrate slowly. - Concomitant CNS depressants: may enhance sedation and respiratory depression. - Abrupt discontinuation: risk of rebound hyperexcitability; taper gradually. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight.

Pregabalin can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Opioids: additive risk of respiratory depression and profound sedation. - Alcohol and other CNS depressants: may cause excessive drowsiness or loss of coordination. - MAO inhibitors: potential for unpredictable CNS effects.

Moderate Interactions (Monitor Closely): - Diuretics: may increase serum Pregabalin concentrations. - Antihypertensives: additive hypotensive effect. - Anticholinergic agents: may exacerbate dry mouth and constipation. - NSAIDs: combined use may heighten risk of renal impairment in susceptible patients.